Lundby Lilli, Krogh Klaus, Jensen Vagn J, Gandrup Per, Qvist Niels, Overgaard Jens, Laurberg Soren
Surgical Research Unit, Department of Surgery L, Aarhus University Hospital, Section TGH, Aarhus, Denmark.
Dis Colon Rectum. 2005 Jul;48(7):1343-9; discussion 1349-52; author reply 1352. doi: 10.1007/s10350-005-0049-1.
Adjuvant radiotherapy in the treatment of rectal cancer has been shown to increase long-term morbidity causing severe anorectal dysfunction with physiologic changes whose interaction remains poorly understood. This study examines long-term anorectal morbidity from adjuvant postoperative radiotherapy.
In a prospective study, patients with Dukes B or C rectal carcinoma were randomized to postoperative radiotherapy or no adjuvant treatment after anterior resection. The long-term effect of radiotherapy on anorectal function in a subset of surviving patients was assessed from a questionnaire on subjective symptoms and from physiology laboratory evaluation and flexible sigmoidoscopy.
Twelve of 15 patients (80 percent) treated with radiotherapy had increased bowel frequency compared with 3 of the 13 patients (23 percent) who did not have radiation therapy (P = 0.003). The former group had loose or liquid stool more often (60 vs. 23 percent, P = 0.05), had fecal incontinence more often (60 vs. 8 percent, P = 0.004), and wore pad more often (47 vs. 0 percent, P = 0.004). They also experienced fecal urgency and were unable to differentiate stool from gas more often. Endoscopy revealed a pale and atrophied mucosa and telangiectasias in the irradiated patients. Anorectal physiology showed a reduced rectal capacity (146 vs. 215 ml, P = 0.03) and maximum squeeze pressure (59 vs. 93 cm H2O, P = 0.003) in the radiotherapy group. Impedance planimetry demonstrated a reduced rectal distensibility in these patients (P < 0.0001).
Adjuvant postoperative radiotherapy after anterior resection causes severe long-term anorectal dysfunction, which is mainly the result of a weakened, less sensitive anal sphincter and an undistensible rectum with reduced capacity.
直肠癌辅助放疗已被证明会增加长期发病率,导致严重的肛肠功能障碍,其生理变化之间的相互作用仍知之甚少。本研究探讨术后辅助放疗引起的长期肛肠发病率。
在一项前瞻性研究中,将Dukes B或C期直肠癌患者在前部切除术后随机分为术后放疗组或无辅助治疗组。通过一份关于主观症状的问卷、生理学实验室评估和乙状结肠镜检查,评估放疗对部分存活患者肛肠功能的长期影响。
接受放疗的15名患者中有12名(80%)排便次数增加,而未接受放疗的13名患者中有3名(23%)出现这种情况(P = 0.003)。前一组出现稀便或水样便的情况更频繁(60% 对23%,P = 0.05),出现大便失禁的情况更频繁(60% 对8%,P = 0.004),使用护垫的情况更频繁(47% 对0%,P = 0.004)。他们还经常出现排便紧迫感,并且更难以区分大便和气体。内镜检查显示,接受放疗的患者黏膜苍白、萎缩,并有毛细血管扩张。肛肠生理学显示,放疗组的直肠容量降低(146 vs. 215 ml,P = 0.03),最大挤压压力降低(59 vs. 93 cm H2O,P = 0.003)。阻抗平面测量显示这些患者的直肠扩张性降低(P < 0.0001)。
前部切除术后的辅助放疗会导致严重的长期肛肠功能障碍,这主要是由于肛门括约肌减弱、敏感性降低以及直肠扩张性降低、容量减小所致。